Peripheral cannabinoids attenuate carcinoma-induced nociception in mice
- 8 January 2008
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 433 (2) , 77-81
- https://doi.org/10.1016/j.neulet.2007.12.053
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptorsJournal of Neuroimmunology, 2007
- Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptorsNature Neuroscience, 2007
- Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesiaEuropean Journal of Pharmacology, 2007
- Activation of peripheral cannabinoid CB1and CB2receptors suppresses the maintenance of inflammatory nociception: a comparative analysisBritish Journal of Pharmacology, 2007
- Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic painPain, 2006
- Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in ratsNeuropharmacology, 2003
- Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer‐related pain behaviors and neurochemical changes in the central nervous systemInternational Journal of Cancer, 2003
- Two distinctive antinociceptive systems in rats with pathological painNeuroscience Letters, 2000
- Cannabinoids as potential new analgesicsLife Sciences, 1999
- Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune SystemToxicology and Applied Pharmacology, 1997